Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (251-260 of 270) with videos related to

Pageof 27
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 11, 2022
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinomaEmily Chan, Jesse K McKenney, Sarah Hawley, et al.
Nucleic Acids Research|December 19, 2022
Dynamic phase separation of the androgen receptor and its coactivators key to regulate gene expressionFan Zhang, Maitree Biswas, Shabnam Massah, et al.
Nature Cell Biology|September 7, 2021
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancerAlastair Davies, Shaghayegh Nouruzi, Dwaipayan Ganguli, et al.
Human Pathology|February 17, 2022
Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosisSamuel Ruder, Yan Gao, Yi Ding, et al.
Advances in Anatomic Pathology|December 13, 2012
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue MicroarraySarah Hawley, Ladan Fazli, Jesse K McKenney, et al.
Genome Biology|August 27, 2014
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancerAlexander W Wyatt, Fan Mo, Kendric Wang, et al.
Cancer Letters|November 7, 2022
UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathwaysLouis Lacombe, Hélène Hovington, Hervé Brisson, et al.
Genome Medicine|February 20, 2019
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesotheliomaRaunak Shrestha, Noushin Nabavi, Yen-Yi Lin, et al.
The Journal of Urology|September 2, 2015
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS CohortLisa F Newcomb, Ian M Thompson, Hilary D Boyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Molecular Characterization of Neuroendocrine-like Bladder CancerJosé Batista da Costa, Ewan A Gibb, Trinity J Bivalacqua, et al.
Pageof 27

Showing results (251-260 of 270) with videos related to

Sort By:
Pageof 27
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 11, 2022
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinomaEmily Chan, Jesse K McKenney, Sarah Hawley, et al.
Nucleic Acids Research|December 19, 2022
Dynamic phase separation of the androgen receptor and its coactivators key to regulate gene expressionFan Zhang, Maitree Biswas, Shabnam Massah, et al.
Nature Cell Biology|September 7, 2021
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancerAlastair Davies, Shaghayegh Nouruzi, Dwaipayan Ganguli, et al.
Human Pathology|February 17, 2022
Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosisSamuel Ruder, Yan Gao, Yi Ding, et al.
Advances in Anatomic Pathology|December 13, 2012
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue MicroarraySarah Hawley, Ladan Fazli, Jesse K McKenney, et al.
Genome Biology|August 27, 2014
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancerAlexander W Wyatt, Fan Mo, Kendric Wang, et al.
Cancer Letters|November 7, 2022
UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathwaysLouis Lacombe, Hélène Hovington, Hervé Brisson, et al.
Genome Medicine|February 20, 2019
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesotheliomaRaunak Shrestha, Noushin Nabavi, Yen-Yi Lin, et al.
The Journal of Urology|September 2, 2015
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS CohortLisa F Newcomb, Ian M Thompson, Hilary D Boyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Molecular Characterization of Neuroendocrine-like Bladder CancerJosé Batista da Costa, Ewan A Gibb, Trinity J Bivalacqua, et al.
Pageof 27